A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

NCT02121301 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratoconjunctivitis Sicca

Interventions

DRUG: Low Dose 0.155µg/mL SkQ1 ophthalmic solution
DRUG: High Dose 1.55µg/mL SkQ1 ophthalmic solution
DRUG: Placebo (Vehicle) opthalmic solution

Sponsor

Mitotech, SA

Collaborators

[object Object]